Context Therapeutics Inc.

Direct answer

Context Therapeutics Inc. is publicly traded on NASDAQ under the ticker CNTX.

Context Therapeutics Inc. (CNTX) is a biopharmaceutical firm in the clinical development stage, dedicated to advancing cancer treatments specifically for women in the United States. Its leading investigational therapy is onapristone extended release (ONA-XR). This compound functions as a potent and selective antagonist of the progesterone receptor, aiming to counteract the resistance often encountered with various...

Can you invest in Context Therapeutics Inc.?

Yes. Context Therapeutics Inc. is publicly traded on NASDAQ under the ticker CNTX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Context Therapeutics Inc.

Detailed equity research is provided by MarketSnap.